Latest news

Filters
January 25, 2024

Genialis and Debiopharm Set Up Biomarker Discovery Collaboration

Read more
January 10, 2024

Debiopharm and ThinkingNodeLife.ai Forge Strategic Partnership to Propel Cancer Drug Development

Read more
January 9, 2024

MedaSystems Secures Additional Funding from Debiopharm Innovation Fund to Accelerate Global Access to Pre-approval Treatment

Read more
January 8, 2024

Debiopharm Extends SunRock Biopharma Partnership for Antibody-Drug Conjugates Targeting HER3 in EGFR Mutated Cancers

Read more
January 5, 2024

Debiopharm and Repare Therapeutics Partner to Explore the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition in Cancer

Read more
December 12, 2023

Le 8e Challenge Qualité de vie du patient récompense BOOTIS.CH, plateforme d’organisation de voyages pour les personnes souffrant d’un handicap

Read more
October 25, 2023

Debiopharm invests over 30 million on innovation when its workforce jumped 33% in Valais in one year

Read more
October 24, 2023

Transfer of Marketing Authorization of Anticancer Drug Elplat® to Takata Pharmaceutical

Read more
September 28, 2023

Debiopharm Innovation Fund Launches New Seed Funding Activity to accelerate digital transformation of cancer care and Pharma R&D

Read more

Stay informed

Don't miss any latest news and announcements on Debiopharm Investment, subscribe to our newsletter.